… in the United States, millions of individuals have reported adverse events (AEs)

… We used VAERS data to examine the frequency of reporting myocarditis

… compared this with historical values

… We examined myocarditis reports in VAERS in the context of sex, age, and dose

… after COVID-19 vaccination in 2021 was 223 times higher

than the average of all vaccines combined for the past 30 years

… a 2500% increase in the absolute number of reports in the first year   [ 2021 ]

… myocarditis occurred most in … males (69%)

… 76% of cases resulted in emergency care and hospitalization

… died (3%)

… more likely after dose 2

… individuals less than 30 years of age were more likely … to acquire myocarditis

… We found a very strong safety signal for COVID-19 vaccine-induced myocarditis

… particularly in children and young adults

… resulted in hospitalization and death

… COVID-19 vaccines induce an uncontrolled expression of potentially lethal SARS-CoV-2 spike protein within human cells … are deterministic for myocarditis, including fatal cases